Skip to main content
SpringerLink
Log in

Viruses and the Innate Immune System

Answers and yet more questions

  • Chapter
Modulation of Host Gene Expression and Innate Immunity by Viruses

  • 691 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Isaacs, A. and Lindenmann, J., 1957, Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147:258–67

    PubMed  CAS  Google Scholar 

  2. Lindenmann, J., 1960, [Interferon and inverse interference]. Z Haut Geschlechtskr 146:287–309

    PubMed  CAS  Google Scholar 

  3. Havell, E.A. and Vilcek, J., 1974, Mass production and some characteristics of human interferon from diploid cells. In Vitro Monogr 47

    Google Scholar 

  4. Strander, H. and Cantell, K., 1967, Further studies on the production of interferon by human leukocyte in vitro. Ann Med Exp Biol Fenn 45:20–9

    PubMed  CAS  Google Scholar 

  5. Nagata, S., Taira, H., Hall, A., Johnsrud, L., Streuli, M., Ecsodi, J., Boll, W., Cantell, K. and Weissmann, C., 1980, Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature 284:316–20

    PubMed  CAS  Google Scholar 

  6. Darnell, J.E., Jr., Kerr, I.M. and Stark, G.R., 1994, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–21

    PubMed  CAS  Google Scholar 

  7. Chang, H.W., Watson, J.C. and Jacobs, B.L., 1992, The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 89:4825–9

    PubMed  CAS  Google Scholar 

  8. Kitajewski, J., Schneider, R.J., Safer, B., Munemitsu, S.M., Samuel, C.E., Thimmappaya, B. and Shenk, T., 1986, Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 45:195–200

    PubMed  CAS  Google Scholar 

  9. Roizman, B. and Knipe, D.M., 2001, Herpes Simplex Viruses and Their Replication. In Fields Virology, (eds. Knipe, D.M. and Howley, P.M.), Lippincott Williams & Wilkins, Philadelphia, Vol. 2, 2399–2460

    Google Scholar 

  10. Garcia-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D.E., Durbin, J.E., Palese, P. and Muster, T., 1998, Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–30

    PubMed  CAS  Google Scholar 

  11. Muller, U., Steinhoff, U., Reis, L.F., Hemmi, S., Pavlovic, J., Zinkernagel, R.M. and Aguet, M., 1994, Functional role of type I and type II interferons in antiviral defense. Science 264:1918–21

    PubMed  CAS  Google Scholar 

  12. Durbin, J.E., Hackenmiller, R., Simon, M.C. and Levy, D.E., 1996, Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443–50

    PubMed  CAS  Google Scholar 

  13. Deonarain, R., Alcami, A., Alexiou, M., Dallman, M.J., Gewert, D.R. and Porter, A.C., 2000, Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol 74:3404–9

    PubMed  CAS  Google Scholar 

  14. Wathelet, M.G., Lin, C.H., Parekh, B.S., Ronco, L.V., Howley, P.M. and Maniatis, T., 1998, Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1:507–18

    PubMed  CAS  Google Scholar 

  15. Marie, I., Durbin, J.E. and Levy, D.E., 1998, Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J 17:6660–9

    PubMed  CAS  Google Scholar 

  16. Haller, O. and Kochs, G., 2002, Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3:710–7

    PubMed  CAS  Google Scholar 

  17. Regad, T. and Chelbi-Alix, M.K., 2001, Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20:7274–86

    PubMed  CAS  Google Scholar 

  18. Liu, Y. and Samuel, C.E., 1996, Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase. J Virol 70:1961–8

    PubMed  CAS  Google Scholar 

  19. Bridgen, A., Weber, F., Fazakerley, J.K. and Elliott, R.M., 2001, Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci USA 98:664–9

    PubMed  CAS  Google Scholar 

  20. Garcin, D., Itoh, M. and Kolakofsky, D., 1997, A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology 238:424–31

    PubMed  CAS  Google Scholar 

  21. Patterson, J.B., Thomas, D., Lewicki, H., Billeter, M.A. and Oldstone, M.B., 2000, V and C proteins of measles virus function as virulence factors in vivo. Virology 267:80–9

    PubMed  CAS  Google Scholar 

  22. Chou, J., Kern, E.R., Whitley, R.J. and Roizman, B., 1990, Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250:1262–6

    PubMed  CAS  Google Scholar 

  23. Brandt, T.A. and Jacobs, B.L., 2001, Both carboxy-and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J Virol 75:850–6

    PubMed  CAS  Google Scholar 

  24. Bossert, B. and Conzelmann, K.K., 2002, Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J Virol 76:4287–93

    PubMed  CAS  Google Scholar 

  25. Parisien, J.P., Lau, J.F. and Horvath, C.M., 2002, STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J Virol 76:6435–41

    PubMed  CAS  Google Scholar 

  26. Park, M.S., Garcia-Sastre, A., Cros, J.F., Basler, C.F. and Palese, P., 2003, Newcastle disease virus V protein is a determinant of host range restriction. J Virol 77:9522–32

    PubMed  CAS  Google Scholar 

  27. Young, D.F., Chatziandreou, N., He, B., Goodbourn, S., Lamb, R.A. and Randall, R.E., 2001, Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol 75:3363–70

    PubMed  CAS  Google Scholar 

  28. Langland, J.O. and Jacobs, B.L., 2002, The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 299:133–41

    PubMed  CAS  Google Scholar 

  29. Smith, E.J., Marie, I., Prakash, A., Garcia-Sastre, A. and Levy, D.E., 2001, IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein. J Biol Chem 276:8951–7

    PubMed  CAS  Google Scholar 

  30. Rivas, C., Gil, J., Melkova, Z., Esteban, M. and Diaz-Guerra, M., 1998, Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. Virology 243:406–14

    PubMed  CAS  Google Scholar 

  31. Davies, M.V., Elroy-Stein, O., Jagus, R., Moss, B. and Kaufman, R.J., 1992, The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 66:1943–50

    PubMed  CAS  Google Scholar 

  32. Carroll, K., Elroy-Stein, O., Moss, B. and Jagus, R., 1993, Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J Biol Chem 268:12837–42

    PubMed  CAS  Google Scholar 

  33. Alcami, A., Symons, J.A. and Smith, G.L., 2000, The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 74:11230–9

    PubMed  CAS  Google Scholar 

  34. Symons, J.A., Alcami, A. and Smith, G.L., 1995, Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551–60

    PubMed  CAS  Google Scholar 

  35. He, B., Gross, M. and Roizman, B., 1997, The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 94:843–8

    PubMed  CAS  Google Scholar 

  36. Poppers, J., Mulvey, M., Khoo, D. and Mohr, I., 2000, Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J Virol 74:11215–21

    PubMed  CAS  Google Scholar 

  37. Peters, G.A., Khoo, D., Mohr, I. and Sen, G.C., 2002, Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J Virol 76:11054–64

    PubMed  CAS  Google Scholar 

  38. Everett, R.D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M. and Parkinson, J., 1998, The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110-and proteasome-dependent loss of several PML isoforms. J Virol 72:6581–91

    PubMed  CAS  Google Scholar 

  39. Melroe, G.T., DeLuca, N.A. and Knipe, D.M., 2004, Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol 78:8411–20

    PubMed  CAS  Google Scholar 

  40. Chee, A.V. and Roizman, B., 2004, Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol 78:4185–96

    PubMed  CAS  Google Scholar 

  41. Burysek, L., Yeow, W.S., Lubyova, B., Kellum, M., Schafer, S.L., Huang, Y.Q. and Pitha, P.M., 1999, Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 73:7334–42

    PubMed  CAS  Google Scholar 

  42. Li, M., Lee, H., Guo, J., Neipel, F., Fleckenstein, B., Ozato, K. and Jung, J.U., 1998, Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 72:5433–40

    PubMed  CAS  Google Scholar 

  43. Lubyova, B. and Pitha, P.M., 2000, Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol 74:8194–201

    PubMed  CAS  Google Scholar 

  44. Burysek, L. and Pitha, P.M., 2001, Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 75:2345–52

    PubMed  CAS  Google Scholar 

  45. Juang, Y.T., Lowther, W., Kellum, M., Au, W.C., Lin, R., Hiscott, J. and Pitha, P.M., 1998, Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci USA 95:9837–42

    PubMed  CAS  Google Scholar 

  46. Leonard, G.T. and Sen, G.C., 1996, Effects of adenovirus E1A protein on interferon-signaling. Virology 224:25–33

    PubMed  CAS  Google Scholar 

  47. Look, D.C., Roswit, W.T., Frick, A.G., Gris-Alevy, Y., Dickhaus, D.M., Walter, M.J. and Holtzman, M.J., 1998, Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871–80

    PubMed  CAS  Google Scholar 

  48. Mathews, M.B. and Shenk, T., 1991, Adenovirus virus-associated RNA and translation control. J Virol 65:5657–62

    PubMed  CAS  Google Scholar 

  49. Ronco, L.V., Karpova, A.Y., Vidal, M. and Howley, P.M., 1998, Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061–72

    PubMed  CAS  Google Scholar 

  50. Li, S., Labrecque, S., Gauzzi, M.C., Cuddihy, A.R., Wong, A.H., Pellegrini, S., Matlashewski, G.J. and Koromilas, A.E., 1999, The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18:5727–37

    PubMed  CAS  Google Scholar 

  51. Barnard, P. and McMillan, N.A., 1999, The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology 259:305–13

    PubMed  CAS  Google Scholar 

  52. Roy, S., Katze, M.G., Parkin, N.T., Edery, I., Hovanessian, A.G. and Sonenberg, N., 1990, Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216–9

    PubMed  CAS  Google Scholar 

  53. Gunnery, S., Rice, A.P., Robertson, H.D. and Mathews, M.B., 1990, Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc Natl Acad Sci USA 87:8687–91

    PubMed  CAS  Google Scholar 

  54. Martinand, C., Montavon, C., Salehzada, T., Silhol, M., Lebleu, B. and Bisbal, C., 1999, RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol 73:290–6

    PubMed  CAS  Google Scholar 

  55. Imani, F. and Jacobs, B.L., 1988, Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc Natl Acad Sci USA 85:7887–91

    PubMed  CAS  Google Scholar 

  56. Foy, E., Li, K., Wang, C., Sumpter, R., Jr., Ikeda, M., Lemon, S.M. and Gale, M., Jr., 2003, Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300:1145–8

    PubMed  CAS  Google Scholar 

  57. Gale, M.J., Jr., Korth, M.J. and Katze, M.G., 1998, Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin Diagn Virol 10:157–62

    PubMed  Google Scholar 

  58. Taylor, D.R., Shi, S.T., Romano, P.R., Barber, G.N. and Lai, M.M., 1999, Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107–10

    PubMed  CAS  Google Scholar 

  59. Melen, K., Fagerlund, R., Nyqvist, M., Keskinen, P. and Julkunen, I., 2004, Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs. J Med Virol 73:536–47

    PubMed  CAS  Google Scholar 

  60. Munoz-Jordan, J.L., Sanchez-Burgos, G.G., Laurent-Rolle, M. and Garcia-Sastre, A., 2003, Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 100:14333–8

    PubMed  CAS  Google Scholar 

  61. Yalamanchili, P., Datta, U. and Dasgupta, A., 1997, Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro. J Virol 71:1220–6

    PubMed  CAS  Google Scholar 

  62. Yalamanchili, P., Harris, K., Wimmer, E. and Dasgupta, A., 1996, Inhibition of basal transcription by poliovirus: a virus-encoded protease (3Cpro) inhibits formation of TBPTATA box complex in vitro. J Virol 70:2922–9

    PubMed  CAS  Google Scholar 

  63. Black, T.L., Barber, G.N. and Katze, M.G., 1993, Degradation of the interferon-induced 68,000-M(r) protein kinase by poliovirus requires RNA. J Virol 67:791–800

    PubMed  CAS  Google Scholar 

  64. Ludwig, S., Wang, X., Ehrhardt, C., Zheng, H., Donelan, N., Planz, O., Pleschka, S., Garcia-Sastre, A., Heins, G. and Wolff, T., 2002, The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76:11166–71

    PubMed  CAS  Google Scholar 

  65. Wang, X., Li, M., Zheng, H., Muster, T., Palese, P., Beg, A.A. and Garcia-Sastre, A., 2000, Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74:11566–73

    PubMed  CAS  Google Scholar 

  66. Lu, Y., Wambach, M., Katze, M.G. and Krug, R.M., 1995, Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222–8

    PubMed  CAS  Google Scholar 

  67. Bergmann, M., Garcia-Sastre, A., Carnero, E., Pehamberger, H., Wolff, K., Palese, P. and Muster, T., 2000, Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74:6203–6

    PubMed  CAS  Google Scholar 

  68. Chen, Z., Li, Y. and Krug, R.M., 1999, Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. Embo J 18:2273–83

    PubMed  CAS  Google Scholar 

  69. Fortes, P., Beloso, A. and Ortin, J., 1994, Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. Embo J 13:704–12

    PubMed  CAS  Google Scholar 

  70. Noah, D.L., Twu, K.Y. and Krug, R.M., 2003, Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3’ end processing of cellular pre-mRNAS. Virology 307:386–95

    PubMed  CAS  Google Scholar 

  71. Lee, T.G., Tomita, J., Hovanessian, A.G. and Katze, M.G., 1990, Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc Natl Acad Sci USA 87:6208–12

    PubMed  CAS  Google Scholar 

  72. Hagmaier, K., Jennings, S., Buse, J., Weber, F. and Kochs, G., 2003, Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist. J Virol 77:2747–52

    PubMed  CAS  Google Scholar 

  73. Thomas, D., Blakqori, G., Wagner, V., Banholzer, M., Kessler, N., Elliott, R.M., Haller, O. and Weber, F., 2004, Inhibition of RNA polymerase II phosphorylation by a viral R interferon antagonist. J Biol Chem 279:31471–7

    PubMed  CAS  Google Scholar 

  74. Weber, F., Bridgen, A., Fazakerley, J.K., Streitenfeld, H., Kessler, N., Randall, R.E. and Elliott, R.M., 2002, Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76:7949–55

    PubMed  CAS  Google Scholar 

  75. Billecocq, A., Spiegel, M., Vialat, P., Kohl, A., Weber, F., Bouloy, M. and Haller, O., 2004, NSs protein of rift valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78:9798–806

    PubMed  CAS  Google Scholar 

  76. Le May, N., Dubaele, S., De Santis, L.P., Billecocq, A., Bouloy, M. and Egly, J.M., 2004, TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116:541–50

    PubMed  Google Scholar 

  77. Basler, C.F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Muhlberger, E., Bray, M., Klenk, H.D., Palese, P. and Garcia-Sastre, A., 2003, The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77:7945–56

    PubMed  CAS  Google Scholar 

  78. Basler, C.F., Wang, X., Muhlberger, E., Volchkov, V., Paragas, J., Klenk, H.D., Garcia-Sastre, A. and Palese, P., 2000, The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 97:12289–94

    PubMed  CAS  Google Scholar 

  79. Garcin, D., Latorre, P. and Kolakofsky, D., 1999, Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol 73:6559–65

    PubMed  CAS  Google Scholar 

  80. Garcin, D., Marq, J.B., Goodbourn, S. and Kolakofsky, D., 2003, The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J Virol 77:2321–9

    PubMed  CAS  Google Scholar 

  81. Garcin, D., Marq, J.B., Iseni, F., Martin, S. and Kolakofsky, D., 2004, A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability. J Virol 78:8799–811

    PubMed  CAS  Google Scholar 

  82. Garcin, D., Marq, J.B., Strahle, L., le Mercier, P. and Kolakofsky, D., 2002, All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its monoubiquitination and degradation. Virology 295:256–65

    PubMed  CAS  Google Scholar 

  83. Gotoh, B., Takeuchi, K., Komatsu, T. and Yokoo, J., 2003, The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 77:3360–70

    PubMed  CAS  Google Scholar 

  84. Takeuchi, K., Komatsu, T., Yokoo, J., Kato, A., Shioda, T., Nagai, Y. and Gotoh, B., 2001, Sendai virus C protein physically associates with Stat1. Genes Cells 6:545–57

    PubMed  CAS  Google Scholar 

  85. Saito, S., Ogino, T., Miyajima, N., Kato, A. and Kohase, M., 2002, Dephosphorylation a failure of tyrosine-phosphorylated STAT1 in IFN-stimulated Sendai virus C protein-expressing cells. Virology 293:205–9

    PubMed  CAS  Google Scholar 

  86. Komatsu, T., Takeuchi, K., Yokoo, J. and Gotoh, B., 2004, C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production. Virology 325:137–48

    PubMed  CAS  Google Scholar 

  87. Didcock, L., Young, D.F., Goodbourn, S. and Randall, R.E., 1999, The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73:9928–33

    PubMed  CAS  Google Scholar 

  88. Andrejeva, J., Poole, E., Young, D.F., Goodbourn, S. and Randall, R.E., 2002, The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the r targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J Virol 76:11379–86

    PubMed  CAS  Google Scholar 

  89. Parisien, J.P., Lau, J.F., Rodriguez, J.J., Ulane, C.M. and Horvath, C.M., 2002, Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J Virol 76:4190–8

    PubMed  CAS  Google Scholar 

  90. Ulane, C.M. and Horvath, C.M., 2002, Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304:160–6

    PubMed  CAS  Google Scholar 

  91. He, B., Paterson, R.G., Stock, N., Durbin, J.E., Durbin, R.K., Goodbourn, S., Randall, R.E. and Lamb, R.A., 2002, Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling. Virology 303:15–32

    PubMed  CAS  Google Scholar 

  92. Poole, E., He, B., Lamb, R.A., Randall, R.E. and Goodbourn, S., 2002, The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology 303:33–46

    PubMed  CAS  Google Scholar 

  93. Young, D.F., Didcock, L., Goodbourn, S. and Randall, R.E., 2000, Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269:383–90

    PubMed  CAS  Google Scholar 

  94. Nishio, M., Tsurudome, M., Ito, M., Kawano, M., Komada, H. and Ito, Y., 2001, High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons. J Virol 75:9165–76

    PubMed  CAS  Google Scholar 

  95. Parisien, J.P., Lau, J.F., Rodriguez, J.J., Sullivan, B.M., Moscona, A., Parks, G.D., Lamb, R.A. and Horvath, C.M., 2001, The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283:230–9

    PubMed  CAS  Google Scholar 

  96. Kubota, T., Yokosawa, N., Yokota, S. and Fujii, N., 2001, C terminal CYS-RICH region of mumps virus structural V protein correlates with block of interferon alpha and gamma signal transduction pathway through decrease of STAT 1-alpha. Biochem Biophys Res Commun 283:255–9

    PubMed  CAS  Google Scholar 

  97. Yokosawa, N., Yokota, S., Kubota, T. and Fujii, N., 2002, C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J Virol 76:12683–90

    PubMed  CAS  Google Scholar 

  98. Palosaari, H., Parisien, J.P., Rodriguez, J.J., Ulane, C.M. and Horvath, C.M., 2003, STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol 77:7635–44

    PubMed  CAS  Google Scholar 

  99. Shaffer, J.A., Bellini, W.J. and Rota, P.A., 2003, The C protein of measles virus inhibits the type I interferon response. Virology 315:389–97

    PubMed  CAS  Google Scholar 

  100. Naniche, D., Yeh, A., Eto, D., Manchester, M., Friedman, R.M. and Oldstone, M.B., 2000, Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J Virol 74:7478–84

    PubMed  CAS  Google Scholar 

  101. Park, M.S., Shaw, M.L., Munoz-Jordan, J., Cros, J.F., Nakaya, T., Bouvier, N., Palese, P., Garcia-Sastre, A. and Basler, C.F., 2003, Newcastle disease virus (NDV)-based assay demonstrates interferon antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol 77:1501–11

    PubMed  CAS  Google Scholar 

  102. Shaw, M.L., Garcia-Sastre, A., Palese, P. and Basler, C.F., 2004, Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 78:5633–41

    PubMed  CAS  Google Scholar 

  103. Rodriguez, J.J., Cruz, C.D. and Horvath, C.M., 2004, Identification of the nuclear export f signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol 78:5358–67

    PubMed  CAS  Google Scholar 

  104. Rodriguez, J.J., Parisien, J.P. and Horvath, C.M., 2002, Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 76:11476–83

    PubMed  CAS  Google Scholar 

  105. Rodriguez, J.J., Wang, L.F. and Horvath, C.M., 2003, Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 77:11842–5

    PubMed  CAS  Google Scholar 

  106. Bossert, B., Marozin, S. and Conzelmann, K.K., 2003, Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 77:8661–8

    PubMed  CAS  Google Scholar 

  107. Spann, K.M., Tran, K.C., Chi, B., Rabin, R.L. and Collins, P.L., 2004, Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78:4363–9

    PubMed  CAS  Google Scholar 

  108. Valarcher, J.F., Furze, J., Wyld, S., Cook, R., Conzelmann, K.K. and Taylor, G., 2003, Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 77:8426–39

    PubMed  CAS  Google Scholar 

  109. Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I.Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., Al Ghonaium, A., Tufenkeji, H., Frayha, H., Al-Gazlan, S., Al-Rayes, H., Schreiber, R.D., Gresser, I. and Casanova, J.L., 2003, Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33:388–91

    PubMed  CAS  Google Scholar 

  110. Hijikata, M., Mishiro, S., Miyamoto, C., Furuichi, Y., Hashimoto, M. and Ohta, Y., 2001, Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (−123 and −88) in vivo and in vitro. Intervirology 44:379–82

    PubMed  CAS  Google Scholar 

  111. Yee, L.J., Tang, J., Gibson, A.W., Kimberly, R., Van Leeuwen, D.J. and Kaslow, R.A., 2001, Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33:708–12

    PubMed  CAS  Google Scholar 

  112. Knapp, S., Hennig, B.J., Frodsham, A.J., Zhang, L., Hellier, S., Wright, M., Goldin, R., Hill, A.V., Thomas, H.C. and Thursz, M.R., 2003, Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 55:362–9

    PubMed  CAS  Google Scholar 

  113. Knapp, S., Yee, L.J., Frodsham, A.J., Hennig, B.J., Hellier, S., Zhang, L., Wright, M., Chiaramonte, M., Graves, M., Thomas, H.C., Hill, A.V. and Thursz, M.R., 2003, Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun 4:411–9

    PubMed  CAS  Google Scholar 

  114. Choi, E.H., Lee, H.J., Yoo, T. and Chanock, S.J., 2002, A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 186:1207–11

    PubMed  CAS  Google Scholar 

  115. Hoebee, B., Rietveld, E., Bont, L., Oosten, M., Hodemaekers, H.M., Nagelkerke, N.J., Neijens, H.J., Kimpen, J.L. and Kimman, T.G., 2003, Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 187:2–11

    PubMed  CAS  Google Scholar 

  116. Honda, K., Sakaguchi, S., Nakajima, C., Watanabe, A., Yanai, H., Matsumoto, M., Ohteki, T., Kaisho, T., Takaoka, A., Akira, S., Seya, T. and Taniguchi, T., 2003, Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci USA 100:10872–7

    PubMed  CAS  Google Scholar 

  117. Edelmann, K.H., Richardson-Burns, S., Alexopoulou, L., Tyler, K.L., Flavell, R.A. and Oldstone, M.B., 2004, Does Toll-like receptor 3 play a biological role in virus infections? Virology 322:231–8

    PubMed  CAS  Google Scholar 

  118. Perry, A.K., Chow, E.K., Goodnough, J.B., Yeh, W.C. and Cheng, G., 2004, Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 199:1651–8

    PubMed  CAS  Google Scholar 

  119. Santini, S.M., Di Pucchio, T., Lapenta, C., Parlato, S., Logozzi, M. and Belardelli, F., 2002, The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J Interferon Cytokine Res 22:1071–80

    PubMed  CAS  Google Scholar 

  120. de Veer, M.J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J.M., Silverman, R.H. and Williams, B.R., 2001, Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69:912–20

    PubMed  Google Scholar 

  121. Geiss, G.K., Carter, V.S., He, Y., Kwieciszewski, B.K., Holzman, T., Korth, M.J., Lazaro, C.A., Fausto, N., Bumgarner, R.E. and Katze, M.G., 2003, Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 77:6367–75

    PubMed  CAS  Google Scholar 

  122. Pestka, S., 2000, The human interferon alpha species and receptors. Biopolymers 55:254–87

    PubMed  CAS  Google Scholar 

  123. Leong, S.R., Chang, J.C., Ong, R., Dawes, G., Stemmer, W.P. and Punnonen, J., 2003, Optimized expression and specific activity of IL-12 by directed molecular evolution. Proc Natl Acad Sci USA 100:1163–8

    PubMed  CAS  Google Scholar 

  124. Thompson, K.A., Strayer, D.R., Salvato, P.D., Thompson, C.E., Klimas, N., Molavi, A., Hamill, A.K., Zheng, Z., Ventura, D. and Carter, W.A., 1996, Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection. Eur J Clin Microbiol Infect Dis 15:580–7

    PubMed  CAS  Google Scholar 

  125. Morrey, J.D., Day, C.W., Julander, J.G., Blatt, L.M., Smee, D.F. and Sidwell, R.W., 2004, Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother 15:101–9

    PubMed  CAS  Google Scholar 

  126. Padalko, E., Nuyens, D., De Palma, A., Verbeken, E., Aerts, J.L., De Clercq, E., Carmeliet, P. and Neyts, J., 2004, The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis. Antimicrob Agents Chemother 48:267–74

    PubMed  CAS  Google Scholar 

  127. Talon, J., Salvatore, M., O’Neill, R.E., Nakaya, Y., Zheng, H., Muster, T., Garcia-Sastre, A. and Palese, P., 2000, Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci USA 97:4309–14

    PubMed  CAS  Google Scholar 

  128. Wang, X., Basler, C.F., Williams, B.R., Silverman, R.H., Palese, P. and Garcia-Sastre, A., 2002, Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J Virol 76:12951–62

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, Mount Sinai School of Medicine, New York, NY, USA

    Megan L. Shaw & Peter Palese

Authors
  1. Megan L. Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Palese
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mount Sinai School of Medicine, New York, NY, USA

    Peter Palese

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer

About this chapter

Cite this chapter

Shaw, M.L., Palese, P. (2005). Viruses and the Innate Immune System. In: Palese, P. (eds) Modulation of Host Gene Expression and Innate Immunity by Viruses. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3242-0_1

Download citation

Publish with us

Policies and ethics

Search

Navigation